U.S. stocks traded mostly lower toward the end of trading, with the Nasdaq Composite dropping around 150 points on Tuesday.
The Dow traded down 0.08% to 29,178.15 while the NASDAQ fell 1.49% to 10,384.62. The S&P 500 also fell, dropping, 0.94% to 3,578.38.
Also check this: Market Volatility Increases After Nasdaq Tumbles Over 100 Points
Leading and Lagging Sectors
Consumer staples shares rose by 1.7% on Tuesday. Leading the sector was strength from e.l.f. Beauty, Inc. ELF and Rite Aid Corporation RAD.
In trading on Tuesday, information technology shares dipped by 0.3%.
Top Headline
ForgeRock, Inc. FORG announced it will be acquired by Thoma Bravo for $2.3 billion.
Equities Trading UP
- DICE Therapeutics, Inc. DICE shares shot up 64% to $40.37 after the company announced topline data from its Phase 1 clinical trial of DC-806. Clinical proof-of-concept in psoriasis patients achieved with a mean percentage reduction in PASI from baseline at 4 weeks of 43.7% in the high dose group.
- Shares of ForgeRock, Inc. FORG got a boost, shooting 49% to $22.58 after the company announced it will be acquired by Thoma Bravo for $2.3 billion.
- Laser Photonics Corporation LASE shares were also up, gaining 70% to $3.17 after the company announced it received an order from the U.S. Navy for delivery this month of an LPC-1000CTH CleanTech Laser Blasting System with an integrated water chiller for submarine MRO.
Equities Trading DOWN
- Orthofix Medical Inc. OFIX shares tumbled 20% to $14.71 after the company and SeaSpine announced they will combine in a merger of equals. The company also announced preliminary Q3 net sales.
- Shares of Rigel Pharmaceuticals, Inc. RIGL were down 18% to $0.93. after the company received guidance from the FDA's review of its re-analysis of data from the FORWARD Phase 3 trial of fostamatinib for warm autoimmune hemolytic anemia (wAIHA). Based on the guidance, Rigel does not expect to file a supplemental marketing application for wAIHA, an autoimmune disorder characterized by the premature destruction of healthy red blood cells (hemolysis). Rigel also announced cutting its workforce by 16%, eliminating 30 positions, primarily in development and administration.
- AZZ Inc. AZZ was down, falling 14% to $33.51 after the company reported worse-than-expected Q2 adjusted EPS results. The company said it will not issue full-year fiscal year 2023 guidance at this time.
Also check out: Bilibili, H World Group And Other Big Losers From Monday
Commodities
In commodity news, oil traded down 1.7% to $89.59, while gold traded up 0.8% at $1,688.70.
Silver traded down 0.2% to $19.575 on Tuesday while copper rose 1% to $3.4635.
Euro zone
European shares were lower today. The eurozone’s STOXX 600 fell 0.56%, London’s FTSE 100 fell 1.06% while Spain’s IBEX 35 Index fell 0.78%. The German DAX declined 0.43%, French CAC 40 fell 0.13% and Italy’s FTSE MIB Index fell 0.87%.
The Bank of England widened its emergency bond buying operation to include purchases of inflation-linked gilts. The jobless rate in the UK declined to 3.5% in the three months to August, versus 3.6% in the earlier period, while average weekly earnings including bonuses rose by 6.0% year-over-year to GBP 617 in the same period. Industrial production in Italy surged by 2.3% from a month ago in August.
Economics
- The NFIB Small Business Optimism Index climbed to a four-month high of 92.1 in September from 91.8 in the previous month.
- The IBD/TIPP Economic Optimism Index declined to 41.6 in October versus a five-month high level of 44.7 in September.
Check out this: Ethereum Falls Below $1,300; Here Are The Top Crypto Movers For Tuesday
COVID-19 Update
The U.S. has the highest number of coronavirus cases and deaths in the world, reporting a total of 98,572,010 cases with around 1,087,970 deaths. India confirmed a total of at least 44,616,390 cases and 528,820 deaths, while France reported over 35,875,620 COVID-19 cases with 155,530 deaths. In total, there were at least 627,104,810 cases of COVID-19 worldwide with more than 6,562,340 deaths.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.